Offering conducted by Rodman & Renshaw at $5.50 per ordinary share
By Devika Patel
Knoxville, Tenn., June 9 – Vascular Biogenics Ltd. said it will conduct a $23.98 million registered direct offering of stock that will be conducted through Rodman & Renshaw.
The company will sell 4,359,091 ordinary shares at $5.50 apiece. The price per share is a 7.63% premium to the June 8 closing share price of $5.11.
Settlement is expected June 10.
Proceeds will be used for clinical programs, working capital and other general corporate purposes.
The biopharmaceutical company is based in Or Yehuda, Israel.
| Issuer: | Vascular Biogenics Ltd.
|
| Issue: | Ordinary shares
|
| Amount: | $23,975,000
|
| Shares: | 4,359,091
|
| Price: | $5.50
|
| Warrants: | No
|
| Agent: | Rodman & Renshaw
|
| Pricing date: | June 9
|
| Settlement date: | June 10
|
| Stock symbol: | Nasdaq: VBLT
|
| Stock price: | $5.11 at close June 8
|
| Market capitalization: | $107.9 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
